HomeBCLI • NASDAQ
add
Brainstorm Cell Therapeutics Inc
Previous close
$0.52
Day range
$0.46 - $0.53
Year range
$0.13 - $3.34
Market cap
33.77M USD
Avg Volume
639.83K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.47M | -51.97% |
Net income | -3.40M | 32.77% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.41M | 52.60% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 779.00K | -65.02% |
Total assets | 3.35M | -57.47% |
Total liabilities | 8.90M | -30.00% |
Total equity | -5.55M | — |
Shares outstanding | 68.45M | — |
Price to book | -6.44 | — |
Return on assets | -163.71% | — |
Return on capital | 154.39% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -3.40M | 32.77% |
Cash from operations | -3.06M | 23.16% |
Cash from investing | — | — |
Cash from financing | 2.54M | -21.39% |
Net change in cash | -524.00K | -141.95% |
Free cash flow | -2.32M | -12.09% |
About
Founded
2000
Website
Employees
29